文献速递疼痛医学

二甲双胍早期治疗减轻复杂性区域疼痛综合征小鼠模型的疼痛和水肿

Early Treatment With Metformin in a Mice Model of Complex Regional Pain Syndrome Reduces Pain and Edema.
PubMed 文献 · Anesth Analg · 2020-01-01

该研究在小鼠胫骨骨折复杂性区域疼痛综合征模型中,于骨折后第14至21天腹腔注射二甲双胍200 mg/kg或生理盐水,评估至第56天的机械性异常性疼痛和挖掘行为。结果显示二甲双胍显著提高von Frey阈值、改善挖掘缺陷并减轻足爪水肿,提示AMPK激活剂可能成为CRPS相关疼痛的治疗靶点。

要点

  • 二甲双胍早期干预可长期减轻CRPS小鼠模型的机械性异常性疼痛。
  • 二甲双胍改善CRPS小鼠的挖掘行为缺陷并减轻足爪水肿。
  • 胫骨骨折后背根神经节AMPK下调,mTOR等通路上调。

核心结论

  • 早期二甲双胍治疗可减轻CRPS小鼠模型的机械性异常性疼痛。
  • AMPK激活剂可能是治疗CRPS相关疼痛的可行靶点。

研究设计与样本

  • 小鼠胫骨骨折模型,骨折组与未骨折组各12只。
  • 骨折后随机分为4组(每组6只):骨折+二甲双胍、骨折+生理盐水、未骨折+二甲双胍、未骨折+生理盐水。
  • 第14至21天每日腹腔注射二甲双胍200 mg/kg或生理盐水。
  • 第25至56天每3天测von Frey、每7天测挖掘行为,去石膏后14天测足爪宽度。

主要发现

  • 第25至56天,二甲双胍组较生理盐水骨折组von Frey阈值曲线下面积均值差42.5 g·d(95%CI 21.0-63.9,P<.001)。
  • 二甲双胍组较生理盐水骨折组挖掘行为曲线下面积均值差546 g·d(95%CI 68-1024,P<.022)。
  • 二甲双胍治疗骨折小鼠足爪宽度(水肿)减轻。
  • 胫骨骨折后背根神经节神经元AMPK下调,mTOR、核糖体S6蛋白和eIF2α上调。

临床怎么用

  • 二甲双胍早期用于骨折后CRPS模型可减轻疼痛和水肿,但尚未确立临床推荐。
  • AMPK通路可能作为CRPS疼痛管理的潜在治疗靶点。

局限性

  • 研究为小鼠模型,结果不能直接外推至临床患者。
  • 样本量较小(每组6只),需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metformin, an adenosine monophosphate (AMP)-activated protein kinase activator, as well as a common drug for type 2 diabetes, has previously been shown to decrease mechanical allodynia in mice with neuropathic pain. The objective of this study is to determine if treatment with metformin during the first 3 weeks after fracture would produce a long-term decrease in mechanical allodynia and improve a complex behavioral task (burrowing) in a mouse tibia fracture model with signs of complex regional pain syndrome. METHODS: Mice were allocated into distal tibia fracture or nonfracture groups (n = 12 per group). The fracture was stabilized with intramedullary pinning and external casting for 21 days. Animals were then randomized into 4 groups (n = 6 per group): (1) fracture, metformin treated, (2) fracture, saline treated, (3) nonfracture, metformin treated, and (4) nonfracture, saline treated. Mice received daily intraperitoneal injections of metformin 200 mg/kg or saline between days 14 and 21. After cast removal, von Frey force withdrawal (every 3 days) and burrowing (every 7 days) were tested between 25 and 56 days. Paw width was measured for 14 days after cast removal. AMP-activated protein kinase downregulation at 4 weeks after tibia fracture in the dorsal root ganglia was examined by immunohistochemistry for changes in the AMP-activated protein kinase pathway. RESULTS: Metformin injections elevated von Frey thresholds (reduced mechanical allodynia) in complex regional pain syndrome mice versus saline-treated fracture mice between days 25 and 56 (difference of mean area under the curve, 42.5 g·d; 95% CI of the difference, 21.0-63.9; P < .001). Metformin also reversed burrowing deficits compared to saline-treated tibial fracture mice (difference of mean area under the curve, 546 g·d; 95% CI of the difference, 68-1024; P < .022). Paw width (edema) was reduced in metformin-treated fracture mice. After tibia fracture, AMP-activated protein kinase was downregulated in dorsal root ganglia neurons, and mechanistic target of rapamycin, ribosomal S6 protein, and eukaryotic initiation factor 2α were upregulated. CONCLUSIONS: The important finding of this study was that early treatment with metformin reduces mechanical allodynia in a complex regional pain syndrome model in mice. Our findings suggest that AMP-activated protein kinase activators may be a viable therapeutic target for the treatment of pain associated with complex regional pain syndrome.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Das V, Kroin JS, Moric M, et al. Early Treatment With Metformin in a Mice Model of Complex Regional Pain Syndrome Reduces Pain and Edema. Anesth Analg. 2020. PMID: 30801357. doi:10.1213/ANE.0000000000004057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。